1. Editor's page

   EditorialNotes Pages: 193 - 193

2. The NIH Consensus Development Conference on Adjuvant Chemotherapy for Breast Cancer — a commentary

   • Marc E. Lippman

   Commentary Pages: 195 - 200

3. Could aminoglutethimide replace adrenalectomy?

   • A. L. Harris

   Review Pages: 201 - 211

4. Progestin therapy for breast cancer

   • William L McGuire
   • Franco Cavalli
   • J Alexieva-Figusch

   Viewpoints Pages: 213 - 220

5. Assessment of malignancy potential in so-called interval mammary carcinomas

   • Anette von Rosen
   • Kerstin Erhardt
   • Gert Auer

   Report Pages: 221 - 227

6. Endocrine therapy testing of human breast cancers in the soft agar clonogenic assay

   • C. Kent Osborne
   • Daniel D. Von Hoff
   • Kathryn Mullins

   Report Pages: 229 - 235

7. Regulation of breast tumor growth by high dose estrogen is independent of the presence of estrogen receptors

   • Verena Hug
   • Benjamin Drewinko
   • George Blumenschein

   Report Pages: 237 - 240

8. Cyclic nucleotide levels in human breast cancer and in rat mammary tissues during tumor development

   • Ella Israeli
   • Batya Raz
   • David Barzilai

   Report Pages: 241 - 248

9. Tumor markers and their significance in the management of breast cancer

   • Roberto Ceriani
   • Elizabeth P. Anderson

   Meeting Report Pages: 249 - 254

10. Growth promoting influences of estradiol, epidermal growth factor, and insulin on human breast cancer: Evidence for differential mechanism of action on tumor cells in vitro

    • Stefano Iacobelli
    • Clara Natoli

    Correspondence Pages: 255 - 256

11. Announcements

    Announcement Pages: 257 - 259